Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Keytruda / Keytruda Qlex
Generic name : Pembrolizumab
Manufactured By : Merck & Co., Inc.
Indications : Treatment of adults and paediatric patients with unresectable or metastatic tumour mutational burden-high (TMB-H ≥13 mutations per megabase) solid tumours that have progressed following prior treatment and have no satisfactory alternative treatment option
Medicine Description : An immunotherapy for adults and eligible paediatric patients with unresectable or metastatic TMB-H solid tumours following prior treatment. Keytruda (Pembrolizumab) blocks the PD-1 protein, helping the immune system recognise and attack cancer cells.
Keytruda and Keytruda Qlex are immunotherapy medicines containing pembrolizumab. They are used to treat various cancers, including certain unresectable or metastatic TMB-H solid tumours when previous treatment has not worked and no satisfactory alternative is available.
Pembrolizumab blocks the PD-1 pathway, helping the immune system recognise and attack cancer cells. This allows immune cells, particularly T cells, to respond more effectively against cancer.
Keytruda is prescribed for eligible adults and paediatric patients with certain cancers, depending on the approved indication. Keytruda Qlex is prescribed for eligible adult patients. A cancer specialist determines suitability based on the diagnosis and treatment history.
Keytruda is administered through intravenous infusion, while Keytruda Qlex is given as a subcutaneous injection. Both must be administered by qualified healthcare professionals according to the prescribed dose and schedule.
Common side effects may include fatigue, muscle and joint pain, skin rash, itching, diarrhoea, nausea, decreased appetite, fever, cough and abdominal pain.
Yes. Pembrolizumab can cause serious immune-related reactions affecting organs such as the lungs, liver, kidneys, intestines and thyroid. Severe skin reactions and allergic reactions may also occur. Seek medical attention if unusual or worsening symptoms develop.
The treatment duration depends on the cancer type, prescribed regimen, treatment response and side effects. Your oncologist will decide how long treatment should continue.
Consult your doctor before consuming alcohol during treatment. Alcohol may worsen certain symptoms or complicate the management of treatment-related side effects.
Pembrolizumab may cause harm to an unborn baby. Women who can become pregnant should use effective contraception during treatment and for 4 months after the last dose.
Keytruda and Keytruda Qlex may interact with other treatments or medicines through their effects on the immune system. Inform your doctor about all prescription medicines, supplements and other treatments you are receiving.
If you miss a scheduled infusion or injection, contact your healthcare provider as soon as possible to arrange another appointment. Do not take an extra dose or change your treatment schedule yourself.
Keytruda and Keytruda Qlex are not oral medicines, so food does not directly affect their administration. Follow your doctor's dietary advice during cancer treatment.
Attend all scheduled appointments and laboratory tests. Inform your doctor about existing medical conditions and other medicines, and promptly report persistent diarrhoea, breathing difficulties, unusual fatigue, yellowing of the skin or other new symptoms.
Store unopened Keytruda and Keytruda Qlex vials in a refrigerator at 2°C to 8°C (36°F to 46°F), protected from light in their original cartons. Do not freeze or shake the vials.
Pharma Five provides medicine consultancy and import facilitation for patients seeking Keytruda / Keytruda Qlex (Pembrolizumab). Assistance with personal-use medicine imports is subject to applicable regulations, prescriptions and supporting documentation. Pharma Five assists in its procurement.